ERSP Press Releases

ERSP Reviews Advertising for ‘Testoril,’ Marketer Voluntarily Discontinues Claims

ERSP has determined that Premium Nutraceuticals, LLC can support certain claims for Testoril, a dietary supplement intended to increase testosterone levels.

Read More

ERSP Finds Kowa Health Care America, Inc. Can Support Performance Claims for ‘Okinawa Life,’ Recommends Marketer Modify Certain Claims

ERSP has determined that Kowa Health Care America, Inc. can support general performance claims for Okinawa Life, a dietary supplement marketed as providing a variety of health benefits. However, ERSP recommended that Kowa discontinue certain claims.

Read More

ERSP Continues to Expand its Review Program

ERSP reported on recent activity under an expanded program to review advertising claims made for lead-generation businesses, as well as the review of telemarketing scripts and calls by companies participating in its new Telemarketing Review Program.

Read More

ERSP Finds Migralex, Inc. Provided Reasonable Basis for Advertising Claims

ERSP has determined that Migralex, Inc. can support performance and establishment claims for Migralex, an over-the-counter product intended for the treatment of headaches.

Read More

ERSP Finds Farr Laboratories, Inc. Can Support Performance Claims for ‘Prosta-Q,’ Recommends Marketer Modify Certain Claims

ERSP determined that Farr Laboratories, LLC can support general performance claims for Prosta-Q, a dietary supplement intended to address the symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), but recommended certain changes.

Read More

ERSP Finds Lonza America Provided Reasonable Basis for Immune System Claims; Recommends Modification to Establishment Claims

ERSP has recommended that Lonza America, Inc., modify certain “clinically” proven claims for the company’s “Alomune” dietary supplement.

Read More